Heparin Market Size & Share, by Product Type (Low Molecular Weight, Unfractionated); Route of Administration (Intravenous Infusion, Subcutaneous Injection); Application (Deep Vein Thrombosis, Heart Attacks, Stroke, Atrial Fibrillation); End-user (Hospitals, Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3402
  • Published Date: Mar 15, 2023
  • Report Format: PDF, PPT

Companies Dominating the Heparin Landscape

top-features-companies
    • Aspen Holdings
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Opocrin S.p.A.
    • LEO Pharma Inc.
    • Baxter
    • Dr. Reddy’s Laboratories Ltd.
    • Pfizer Inc.
    • B. Braun Medical Inc.
    • Bioiberica S.A.U.
    • Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
    • Fresenius Kabi Canada

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Amcor Group GmbH has launched its latest OmniPack PET bottles to meet the requirements for e-commerce-ready packaging. Amcor has designed a family of stock PET bottles that help co-packers to meet demanding requirements for e-commerce-ready packaging.

  • ALPLA Group along with Voslaur has entered into a partnership to develop a new PET bottle for the Austrian market that will reduce the carbon footprint by 30% and reduces bottle weight by almost 90% in comparison to reusable substitute made up of glass.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 3402
  • Published Date: Mar 15, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The higher number of patients with cancer, increased prevalence of chronic disease, rising cases of thromboembolism, and road accidents are a few factors likely to propel the market growth.

The market is anticipated to attain a CAGR of 4% over the forecast period, i.e., 2023-2035.

Lack of raw materials, higher prices of certain products, and side effects of heparin are the few factors likely to hamper market growth.

The market in North America is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Aspen Holdings and Opocrin S.p.A ., Leo Pharma Inc, Baxter, Dr.Reddy’s Laboratories Ltd., Pfizer Inc., B.Braun Medical Inc., Bioberica S.A.U., Hebei Changshan Biochemical Pharmaceutical Co., Ltd., Fresenius Kabi Canada, and so on.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product type, route of administration, application, end user, and region.

The heart stroke segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying